Zdrowie i gospodarka · 19/09/2023

FDA Releases Draft Guidance on Regulatory Considerations for Prescription Drug Use-Related Software

The Food and Drug Administration (FDA) has released a draft guidance document outlining its regulatory approach to software used with prescription drugs, which will help industry stakeholders understand FDA's application of its drug labeling authorities.